Current Appointments & Affiliations
Associate Professor of Medicine
·
2022 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2023 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Grants
A phase IIIb study to characterize the effectiveness and safety of ADJUVANT ribociclib in broader and closer to real-World patIent populations in stage II anD stage III Early breast canceR (ADJUVANT WIDER)
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2024 - 2031View All Grants
Education, Training & Certifications
St George's Hospital Medical School (United Kingdom) ·
1984
M.B.B.S.